ASX - By Stock
|
IVX |
Approval and Commencement of clinical Trials Australian Government Cancer.
|
|
matakus
|
2 |
1.1K |
5 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
2
|
1.1K
|
5
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Initial Proof-of-Concept results show INV043 to be effective
|
|
matakus
|
49 |
24K |
1 |
29/05/21 |
29/05/21 |
ASX - By Stock
|
49
|
24K
|
1
|
|
ASX - By Stock
|
IVX |
Re:
Recent Trading
|
|
matakus
|
6 |
2.5K |
0 |
21/08/20 |
21/08/20 |
ASX - By Stock
|
6
|
2.5K
|
0
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Preliminary data links Photosoft with immune response
|
|
matakus
|
12 |
7.2K |
0 |
30/04/20 |
30/04/20 |
ASX - By Stock
|
12
|
7.2K
|
0
|
|
ASX - By Stock
|
IVX |
Re:
Herald Sun write up article
|
|
matakus
|
11 |
6.6K |
1 |
09/12/19 |
09/12/19 |
ASX - By Stock
|
11
|
6.6K
|
1
|
|
ASX - By Stock
|
IVX |
Re:
2nd quarter update
|
|
matakus
|
19 |
11K |
1 |
07/05/19 |
07/05/19 |
ASX - By Stock
|
19
|
11K
|
1
|
|
ASX - By Stock
|
IVX |
Re:
6c Price Target - BUY - Research report just out
|
|
matakus
|
44 |
25K |
4 |
02/04/19 |
02/04/19 |
ASX - By Stock
|
44
|
25K
|
4
|
|
ASX - By Stock
|
IVX |
Re:
6c Price Target - BUY - Research report just out
|
|
matakus
|
44 |
25K |
5 |
01/04/19 |
01/04/19 |
ASX - By Stock
|
44
|
25K
|
5
|
|
ASX - By Stock
|
IVX |
Hot off the Press
|
|
matakus
|
4 |
2.0K |
3 |
28/03/19 |
28/03/19 |
ASX - By Stock
|
4
|
2.0K
|
3
|
|
ASX - By Stock
|
IVX |
Re:
What is it worth ?
|
|
matakus
|
16 |
11K |
6 |
24/03/19 |
24/03/19 |
ASX - By Stock
|
16
|
11K
|
6
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Corporate Update and Investor Presentation - Q1 2019
|
|
matakus
|
28 |
9.3K |
2 |
07/03/19 |
07/03/19 |
ASX - By Stock
|
28
|
9.3K
|
2
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Corporate Update and Investor Presentation - Q1 2019
|
|
matakus
|
28 |
9.3K |
7 |
07/03/19 |
07/03/19 |
ASX - By Stock
|
28
|
9.3K
|
7
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Corporate Update and Investor Presentation - Q1 2019
|
|
matakus
|
28 |
9.3K |
0 |
01/03/19 |
01/03/19 |
ASX - By Stock
|
28
|
9.3K
|
0
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Appendix 4C - December quarter
|
|
matakus
|
6 |
2.9K |
0 |
01/02/19 |
01/02/19 |
ASX - By Stock
|
6
|
2.9K
|
0
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Appendix 4C - December quarter
|
|
matakus
|
6 |
2.9K |
1 |
01/02/19 |
01/02/19 |
ASX - By Stock
|
6
|
2.9K
|
1
|
|
ASX - By Stock
|
IVX |
Re:
50 c by christmas
|
|
matakus
|
42 |
31K |
2 |
20/11/18 |
20/11/18 |
ASX - By Stock
|
42
|
31K
|
2
|
|
ASX - By Stock
|
IVX |
Re:
50 c by christmas
|
|
matakus
|
42 |
31K |
3 |
20/11/18 |
20/11/18 |
ASX - By Stock
|
42
|
31K
|
3
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Invion collaborates to develop powerful skin cancer gel
|
|
matakus
|
8 |
3.8K |
4 |
13/11/18 |
13/11/18 |
ASX - By Stock
|
8
|
3.8K
|
4
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Invion collaborates to develop powerful skin cancer gel
|
|
matakus
|
8 |
3.8K |
1 |
13/11/18 |
13/11/18 |
ASX - By Stock
|
8
|
3.8K
|
1
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Spin out of respiratory assets for development in China
|
|
matakus
|
14 |
8.6K |
1 |
05/09/18 |
05/09/18 |
ASX - By Stock
|
14
|
8.6K
|
1
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Photosoft efficiently destroys ovarian cancer cells in vitro
|
|
matakus
|
42 |
28K |
5 |
05/07/18 |
05/07/18 |
ASX - By Stock
|
42
|
28K
|
5
|
|
ASX - By Stock
|
IVX |
Re:
Investors R Rushing
|
|
matakus
|
111 |
63K |
3 |
02/02/18 |
02/02/18 |
ASX - By Stock
|
111
|
63K
|
3
|
|
ASX - By Stock
|
IVX |
Re:
IVX share price
|
|
matakus
|
18 |
10K |
0 |
18/01/18 |
18/01/18 |
ASX - By Stock
|
18
|
10K
|
0
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Appendix 4C - quarterly
|
|
matakus
|
24 |
9.8K |
4 |
12/08/17 |
12/08/17 |
ASX - By Stock
|
24
|
9.8K
|
4
|
|
ASX - By Stock
|
IVX |
Re:
Anyone home ?
|
|
matakus
|
32 |
14K |
1 |
22/06/17 |
22/06/17 |
ASX - By Stock
|
32
|
14K
|
1
|
|
ASX - By Stock
|
IVX |
Interesting!
|
|
matakus
|
9 |
4.5K |
6 |
14/04/17 |
14/04/17 |
ASX - By Stock
|
9
|
4.5K
|
6
|
|
ASX - By Stock
|
IVX |
Phase 3 trial for inv 102 ?
|
|
matakus
|
4 |
3.1K |
4 |
08/04/17 |
08/04/17 |
ASX - By Stock
|
4
|
3.1K
|
4
|
|
ASX - By Stock
|
IVX |
Webb-Site
|
|
matakus
|
8 |
3.4K |
0 |
15/03/17 |
15/03/17 |
ASX - By Stock
|
8
|
3.4K
|
0
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Becoming a substantial holder-IVX.AX
|
|
matakus
|
8 |
3.3K |
2 |
08/09/16 |
08/09/16 |
ASX - By Stock
|
8
|
3.3K
|
2
|
|
ASX - By Stock
|
IVX |
Re:
Ann: App 4E, Annual and Financial Report FY2016-IVX.AX
|
|
matakus
|
16 |
5.0K |
9 |
02/09/16 |
02/09/16 |
ASX - By Stock
|
16
|
5.0K
|
9
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Appendix 4C - quarterly-IVX.AX
|
|
matakus
|
27 |
8.4K |
2 |
02/08/16 |
02/08/16 |
ASX - By Stock
|
27
|
8.4K
|
2
|
|
ASX - By Stock
|
IVX |
Re:
IVX is moving...
|
|
matakus
|
21 |
8.9K |
3 |
13/06/16 |
13/06/16 |
ASX - By Stock
|
21
|
8.9K
|
3
|
|
ASX - By Stock
|
IVX |
Re:
What is the value of IVX
|
|
matakus
|
19 |
9.4K |
1 |
18/04/16 |
18/04/16 |
ASX - By Stock
|
19
|
9.4K
|
1
|
|
ASX - By Stock
|
IVX |
Re:
What is the value of IVX
|
|
matakus
|
19 |
9.4K |
0 |
18/04/16 |
18/04/16 |
ASX - By Stock
|
19
|
9.4K
|
0
|
|
ASX - By Stock
|
IVX |
Re:
General Discussion
|
|
matakus
|
23 |
6.5K |
2 |
23/12/15 |
23/12/15 |
ASX - By Stock
|
23
|
6.5K
|
2
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Smoking cessation trial results of ongoing data analysis
|
|
matakus
|
33 |
9.9K |
0 |
26/11/15 |
26/11/15 |
ASX - By Stock
|
33
|
9.9K
|
0
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Smoking cessation trial results of ongoing data analysis
|
|
matakus
|
33 |
9.9K |
8 |
25/11/15 |
25/11/15 |
ASX - By Stock
|
33
|
9.9K
|
8
|
|
ASX - By Stock
|
IVX |
Re:
Trades
|
|
matakus
|
10 |
2.7K |
3 |
09/11/15 |
09/11/15 |
ASX - By Stock
|
10
|
2.7K
|
3
|
|
ASX - By Stock
|
IVX |
Re:
What's next
|
|
matakus
|
14 |
4.1K |
0 |
29/10/15 |
29/10/15 |
ASX - By Stock
|
14
|
4.1K
|
0
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Invion - successful completion of P2 study of INV102
|
|
matakus
|
85 |
20K |
3 |
07/10/15 |
07/10/15 |
ASX - By Stock
|
85
|
20K
|
3
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Invion - successful completion of P2 study of INV102
|
|
matakus
|
85 |
20K |
6 |
07/10/15 |
07/10/15 |
ASX - By Stock
|
85
|
20K
|
6
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Invion - successful completion of P2 study of INV102
|
|
matakus
|
85 |
20K |
3 |
07/10/15 |
07/10/15 |
ASX - By Stock
|
85
|
20K
|
3
|
|
ASX - By Stock
|
IVX |
Re:
and further
|
|
matakus
|
44 |
13K |
2 |
18/09/15 |
18/09/15 |
ASX - By Stock
|
44
|
13K
|
2
|
|
ASX - By Stock
|
IVX |
Re:
Share register
|
|
matakus
|
9 |
3.0K |
0 |
07/09/15 |
07/09/15 |
ASX - By Stock
|
9
|
3.0K
|
0
|
|
ASX - By Stock
|
IVX |
Re:
Ugly step sister
|
|
matakus
|
9 |
3.8K |
0 |
19/08/15 |
19/08/15 |
ASX - By Stock
|
9
|
3.8K
|
0
|
|
ASX - By Stock
|
IVX |
Re:
Ugly step sister
|
|
matakus
|
9 |
3.8K |
2 |
19/08/15 |
19/08/15 |
ASX - By Stock
|
9
|
3.8K
|
2
|
|
ASX - By Stock
|
IVX |
Re:
Ann: INV103 ala-Cpn10 clinical trial in lupus complete
|
|
matakus
|
11 |
3.9K |
5 |
18/08/15 |
18/08/15 |
ASX - By Stock
|
11
|
3.9K
|
5
|
|
ASX - By Stock
|
IVX |
Re:
Biotech Business Strategies
|
|
matakus
|
4 |
1.6K |
4 |
14/08/15 |
14/08/15 |
ASX - By Stock
|
4
|
1.6K
|
4
|
|
ASX - By Stock
|
IVX |
Re:
Cash position
|
|
matakus
|
11 |
4.5K |
6 |
06/08/15 |
06/08/15 |
ASX - By Stock
|
11
|
4.5K
|
6
|
|
ASX - By Stock
|
IVX |
Re:
Van Leeuwenhoeck Research - values at 100mil
|
|
matakus
|
2 |
1.4K |
1 |
04/08/15 |
04/08/15 |
ASX - By Stock
|
2
|
1.4K
|
1
|
|